MedicinesFAQ

Modakafusp Alfa Uses, Dosage, Side Effects and more

Modakafusp Alfa is under investigation in clinical trial NCT03215030 (A Study to Investigate the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of TAK-573 in Participants With Refractory Multiple Myeloma (MM)).

Attribute Details
Trade Name Modakafusp Alfa
Generic Modakafusp alfa
Modakafusp alfa Other Names Anti-CD38-targeted IGG4-attenuated IFNA TAK-573, Modakafusp alfa
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: January 7, 2025 at 1:49 am
   

Innovators Monograph


*** Taking medicines without doctor's advice can cause long-term problems.